Icaritin and icariin reduce p-Tau levels in a cell model of Alzheimer's disease by downregulating glycogen synthase kinase 3β.
Sign Up to like & getrecommendations! Published in 2021 at "Biotechnology and applied biochemistry"
DOI: 10.1002/bab.2114
Abstract: AIMS This study aimed to explore the neuroprotective effect of icariin/icaritin (ICA/ICT) and the role of ICA/ICT in the treatment of Alzheimer's disease (AD). METHODS ICA and ICT were used to treat okadaic acid (OA)-induced… read more here.
Keywords: glycogen synthase; tau; ica ict; alzheimer disease ... See more keywords